Butterfly Network Releases iQ+ Vet Ultrasound, the Next Big Shift in Veterinary Medicine, with International Expansion and New Partners
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), an innovative digital health company that is working to democratize medical imaging and improve global health equity, is ushering in the next big shift in veterinary medicine with the launch of the new Butterfly iQ+ Vet. The second-generation device brings sharper imaging, a new procedural guidance tool, and hardware improvements that make the solution more powerful, versatile, and easy-to-use.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211005005313/en/
New iQ+ Vet Ultrasound (Photo: Business Wire)
“Veterinarians provide incredible care and face the unique challenge of serving patients that cannot speak,” said Todd Fruchterman, MD, PhD, Butterfly’s President and Chief Executive Officer. “They need clinical information at their fingertips to help them make more informed decisions and efficiently deliver positive patient outcomes. This is where Butterfly iQ+ Vet comes in — we’re creating a new shift in care centered around acquiring crucial information from inside the body that our system allows to be utilized in real-time.”
iQ+ Vet has been thoughtfully designed to powerfully serve veterinarians in a variety of care settings.
Sharp imaging, fast answers
Over 800 hours of engineering work dedicated to optimizing veterinary-specific clinical presets have resulted in vastly improved imaging across applications. iQ+ Vet comes equipped with a suite of powerful new capabilities like color-doppler sensitivity and increased max depth, helping veterinarians collect the image they need to provide more informed care.
The innovative Needle Viz™ tool is now available to veterinarians within five clinical presets (Bladder, MSK, MSK Equine, Small Organ, and Vascular). The ability to visualize needles in-plane will help veterinarians perform more confident fine needle aspirates, and quickly place lines and injections with greater certainty in emergency care situations.
Ease of use
Improvements throughout hardware and software now make it easier for veterinarians to take full advantage of iQ+ Vet’s diagnostic power. A 15% smaller probe face and 10% shorter probe allows easier maneuvering during a wide variety of scans. Up to 20% increase in battery life and improved continuous run time before thermal shut-off ensures that iQ+ Vet functions even longer in the clinic or in the field. Butterfly’s veterinary software now includes customizable worksheets, which help users capture the precise information needed for each individual patient.
Compatibility and pricing flexibility
Now with Android compatibility, and the option for either a USB-C or Lightning cable, iQ+ Vet introduces an entire new group of veterinarians and practices to the diagnostic power of handheld ultrasound. Additionally, Butterfly has introduced flexible pricing options to meet the needs of veterinary customers across different care settings, including rental and outright purchase options.
Global expansion and partnerships
With the new value the device provides, and growing global demand, Butterfly has now made iQ+ Vet available for purchase in 19 new international markets: Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
The international expansion has enabled exciting new partnerships. Butterfly is expanding its collaboration with MWI Animal Health, a leading distributor of animal health products and services. MWI UK will support the distribution of Butterfly iQ+ Vet to veterinary practices in the United Kingdom. Butterfly is also launching a new partnership in Australia and New Zealand with REM SYSTEMS, part of the Paragon Care Group, an established veterinary distributor. These are important first steps in the growth of Butterfly’s veterinary presence outside of the United States.
Within the United States, Butterfly is growing its impact with the announcement of a large-scale innovation partnership with Rarebreed Veterinary Partners, a strategic partner that grows and supports veterinary clinics across the Eastern US. Rarebreed will deploy iQ+ Vet system-wide across their innovative community of veterinary practices.
“Rarebreed is excited to partner with Butterfly to make ultrasound accessible to more patients,” said Dan Espinal, Rarebreed co-founder and CEO. “Rarebreed exists to enhance the standard of care across the profession and bring innovation to our partner practices. Ultrasound should be an integral part of almost any diagnostic workup.”
"Our partnership with Rarebreed to deploy iQ+ Vet system-wide is a great example of the recognition of iQ+ Vet's potential and impact for leading veterinary practices to improve the care they deliver," said Darius Shahida, Butterfly Network's Chief Strategy & Business Development Officer. "Not only will Rarebreed's veterinarians incorporate this powerful diagnostic tool across their practices to deliver new and quicker insights, but this deployment will also further strengthen the bond these veterinarians have with their pet-owners who seek the best care for their pets."
By establishing partnerships like these, and by increasing access to this diagnostic solution, Butterfly has the potential to shift veterinary medicine. The powerful, multi-species, and easy-to-use imaging solution will help veterinarians around the world capitalize on diagnostic opportunities and provide more effective care.
Butterfly will be hosting a virtual launch event on October 5, 2021 at 5 p.m. EDT to share more details. Reserve your seat today on Butterfly’s veterinary website. Butterfly iQ+ Vet will be available for sale online in the geographies where the product is commercially available by the end of the day.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011 and recently listed on the NYSE through a merger with Longview Acquisition Corp (NYSE: BFLY), Butterfly Network is the creator of the world's most advanced handheld, single-probe, whole-body veterinary ultrasound system, Butterfly iQ+ Vet. Butterfly’s mission is to enable universal access to superior medical imaging, and part of that mission is to enable the scanning of every animal at each veterinary visit. Through its proprietary Ultrasound-on-ChipTM technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ Vet can be purchased online by veterinary practitioners in approved countries at the store or by contacting sales at firstname.lastname@example.org.
Rarebreed Veterinary Partners is a thriving community of veterinary hospitals that goes the extra mile to create exceptional work experiences, one partnership or team member at a time. We pride ourselves on building trusted, lasting relationships with our partner hospitals, with a goal to provide exceptional patient care, outstanding client service and an amazing work experience. We continue to build a broad network of practices that values healthcare teams by offering them the innovation and tools necessary to grow, improve and reimagine the veterinary experience. For more information, visit www.rarebreedvet.com.
Forward Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company’s expectations with respect to future performance and development of products and services. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the impact of COVID-19 on the Company’s business; the ability to recognize the anticipated benefits of the business combination; the Company’s ability to grow and manage growth profitably; the success, cost and timing of the Company’s product and service development activities; the potential attributes and benefits of the Company’s products and services; the Company’s ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company’s ability to identify, in-license or acquire additional technology; the Company’s ability to maintain its existing license, manufacture, supply and distribution agreements; the Company’s ability to compete with other companies currently marketing or engaged in the development of products and services that the Company is currently marketing or developing; changes in applicable laws or regulations; the size and growth potential of the markets for the Company’s products and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of the Company’s products and services and reimbursement for medical procedures conducted using its products and services; the Company’s estimates regarding expenses, revenue, capital requirements and needs for additional financing; the Company’s financial performance; the Company’s ability to raise financing in the future; and other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions you not to place undue reliance upon any forward-looking statements, which speak only as of the date of this press release. The Company does not undertake or accept any obligation or undertake to release publicly any updates or revisions to any forward-looking statements to reflect any change in the Company’s expectations or any change in events, conditions or circumstances on which any such statement is based.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Peru Holds a Ribbon Cutting Ceremony at Its Pavilion at Dubai Expo and Wins 4 World Travel Awards22.10.2021 20:15:00 EEST | Press release
The Dubai World Expo took place in an electrifying musical atmosphere where thousands of attendees were captivated by the variety of artistic, musical and cultural expressions that characterize the different regions of Peru. All this was part of the inauguration of the Peru Pavilion at the most important cultural event in the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211022005454/en/ Peru inaugurated its Pavilion at Expo 2020 Dubai and received four awards from the “Tourism Oscars.” (Photo: Business Wire) The Peru Pavilion was inaugurated by the Commissioner General for Peru at the Expo, Amora Carbajal, and Najeeb Mohammed Al-Ali, Executive Director of Expo 2020 Dubai, in front of official representatives from different country pavilions. “The purpose of the pavilion is to offer a complete learning experience about ancient Peruvian wisdom throughout the visit, communicating the importance of the heritage, biodive
Schlumberger Announces Third-Quarter 2021 Results22.10.2021 13:50:00 EEST | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the third-quarter 2021. Third-Quarter Results (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2021 Jun. 30, 2021 Sept. 30, 2020 Sequential Year-on-year Revenue* $5,847 $5,634 $5,258 4% 11% Income (loss) before taxes - GAAP basis $691 $542 $(54) 28% n/m Net income (loss) - GAAP basis $550 $431 $(82) 28% n/m Diluted EPS (loss per share) - GAAP basis $0.39 $0.30 $(0.06) 30% n/m Adjusted EBITDA** $1,296 $1,198 $1,018 8% 27% Adjusted EBITDA margin** 22.2% 21.3% 19.4% 90 bps 280 bps Pretax segment operating income** $908 $807 $575 12% 58% Pretax segment operating margin** 15.5% 14.3% 10.9% 120 bps 460 bps Net income, excluding charges & credits** $514 $431 $228 19% 126% Diluted EPS, excluding charges & credits** $0.36 $0.30 $0.16 20% 125% Revenue by Geography International $4,675 $4,511 $4,210 4% 11% North America* 1,129 1,083 1,034 4% 9% Other 43 40 14 n/m n/m $5,847 $5,634 $5,258 4% 11% *Schlumbe
Disruptive.Asia: Huawei's Ryan Ding and Peng Song Discuss How Operators Can Leverage Connectivity to Unlock New Growth22.10.2021 13:30:00 EEST | Press release
Disruptive.Asia reported that Ryan Ding and Peng Song stressed the growing importance of connectivity in driving industry growth and generating value amid a rapidly evolving landscape at the 7th Ultra-Broadband Forum (UBBF 2021) in Dubai, which is jointly hosted by the UN Broadband Commission and Huawei. Ding, Executive Director of the Board and President of the Carrier Business Group, Huawei, said that connectivity has made it possible to innovate, especially in a digital age where increasing efficiency has become paramount. The pandemic has also ushered a paradigm shift in connectivity, as homes turned into multi-functional centers for education, work, and business. It became increasingly clear that connectivity not only drives digital economies forward but also maintains the functioning of society. Peng, President of the Global Carrier Marketing & Solution Sales Department, Huawei, said that looking at connectivity through Huawei's C.A.F (Coverage, Architecture and Fusion) model can
Suzano Brings Its Target for Capturing 40 Million Tons of Carbon From the Atmosphere Forward To 202522.10.2021 13:19:00 EEST | Press release
Suzano, the world's leading eucalyptus pulp producer and a global benchmark in the manufacture of bioproducts developed from eucalyptus, announces today that it has revised one of its 14 long-term goals – collectively known as Suzano’s “Commitments to Renewing Life”*. Suzano’s goal to remove 40 million tons of carbon from the air by 2030 has been brought forward by five years to 2025. With this revision, Suzano reinforces its capacity to make an even more positive contribution to the planet's climate by achieving net carbon removals from the atmosphere at a faster pace than previously expected. The new five-year target will be supported by the expansion of Suzano’s forest covering which will involve both an uplift in commercial planting operations and setting aside new designated conservation areas that were previously anthropized. Alongside these improvements, Suzano will maintain its focus on reducing carbon emissions across its own operations and supply chain and will continue to im
AntChain Launches Its First Security Chip and New Blockchain Platform Powered by Privacy Computing Technology22.10.2021 13:01:00 EEST | Press release
AntChain, the flagship technology brand of Ant Group, today unveiled two new products at the Apsara Conference 2021 in Hangzhou – the FAIR platform and the T1 security chip – to ensure the security and trustworthiness of data flows within blockchain networks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211022005166/en/ Yan Ying, technical director of AntChain, unveiled the FAIR platform at the Apsara Conference on October 22, 2021. (Photo: Business Wire) Based on AntChain’s upgraded technical architecture, the FAIR platform natively integrates privacy-preserving computation (PPC) and blockchain technologies in a unified platform, unleashing the value of data flows over their entire lifecycle. FAIR is designed to address pain points in multi-party collaboration on data flows, which is increasingly common on the industrial internet. It replaces traditional “PPC plus blockchain” dual-system architecture, integrating the two
Total Telecom: Maximizing the Value of Connectivity22.10.2021 13:00:00 EEST | Press release
Total Telecom reported that i ndustry leaders gathered recently at Ultra-Broadband Forum 2021, organized by UN Broadband Commission and Huawei, held in Dubai to discuss building future-proof networks sustainably. Total Telecom thinks that the expectations from digital connectivity have been redefined in the last one year. From conducting financial transactions online to remote factory management, the digital way of life is becoming pervasive. "Connectivity reshaped how we live and work when the pandemic hit in 2020. Connectivity is more than an expansion of functions, it is an emotional bond. As long as there is connectivity, there is a bond. Where there is connectivity, there is innovation. It presents us with unlimited possibilities. I believe in our shared mission to create a connected world," says Ryan Ding, Executive Director of the Board, President of the Carrier BG, Huawei, in his inaugural address. The C.A.F (Coverage, Architecture and Fusion) model is emerging as a way for the
Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers22.10.2021 12:30:00 EEST | Press release
Egle Therapeutics SAS (Egle), an emerging biotechnology company focused on developing First-In-Class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases, today announces that it has completed a €40M ($46.4M) Series A financing. The Series A was co-led by LSP and Bpifrance through their InnoBio 2 fund. Fund+, Bioqube Ventures and Takeda Ventures, Inc. also participated in this round. Egle Therapeutics was founded in early 2020 with a vision to become a game changer in the field of Tregs immunomodulation through the unique concept of Tregs starving and specifically targeting the most immunosuppressive ones. Spun out of Institut Curie, Egle’s scientific foundation leverages unprecedented, computational-based, IL-2 modified variants and newly tumor-associated Treg targets to build a furnished pipeline of First-In-Class immunocytokines against Tregs. The new capital will be used primarily to advance 2 leads assets into the clinic and f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom